WASHINGTON (MedPage Today) -- The FDA has approved a DNA test designed to gauge the progress of antiviral therapy in solid organ transplant patients being treated for cytomegalovirus.
via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment